praziquantel has been researched along with Angiogenesis, Pathologic in 2 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect of prolonged administration of bevacizumab with praziquantel was also assessed through parasitic load, protective index, granuloma and fibrous tissue evaluation." | 3.96 | Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weapon. ( El-Anwar, N; Hasby Saad, MA, 2020) |
| " The current study is to evaluate the performance of Paeoniflorin (PAE) as an anti-angiogenic therapy, being a powerful anti-fibrotic, compared to artemether (ART) and praziqantel (PZQ) in schistosomiasis mansoni BALB/c mice." | 3.91 | Paeoniflorin in experimental BALB/c mansoniasis: A novel anti-angiogenic therapy. ( Abd El-Aal, NF; Abdelbary, EH, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasby Saad, MA | 1 |
| El-Anwar, N | 1 |
| Abd El-Aal, NF | 1 |
| Abdelbary, EH | 1 |
2 other studies available for praziquantel and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Bevacizumab as a potential anti-angiogenic therapy in schistosomiasis: A double-edged, but adjustable weapon.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Chronic Disease; Granuloma; Liver Diseases; Male; Mic | 2020 |
Paeoniflorin in experimental BALB/c mansoniasis: A novel anti-angiogenic therapy.
Topics: Actins; Angiogenesis Inhibitors; Animals; Anthelmintics; Antigens, CD34; Artemether; Down-Regulation | 2019 |